Invited Mini Review : Innate immune recognition of respiratory syncytial virus infection = Invited Mini Review : Innate immune recognition of respiratory syncytial virus infection

다국어 초록 (Multilingual Abstract)

Respiratory syncytial virus (RSV) is the leading cause of respiratory infection in infants and young children. Severe clinical manifestation of RSV infection is a bronchiolitis, which is common in infants under six months of age. Recently, RSV has been recognized as an important cause of respiratory infection in older populations with cardiovascular morbidity or immunocompromised patients. However, neither a vaccine nor an effective antiviral therapy is currently available. Moreover, the interaction between the host immune system and the RSV pathogen during an infection is not well understood. The innate immune system recognizes RSV through multiple mechanisms. The first innate immune RSV detectors are the pattern recognition receptors (PRRs), including toll-like receptors (TLRs), retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), and nucleotide-biding oligomerization domain (NOD)-like receptors (NLRs). The following is a review of studies associated with various PRRs that are responsible for RSV virion recognition and subsequent induction of the antiviral immune response during RSV infection. [BMB Reports 2014; 47(4): 184-191]

참고문헌 (Reference)

1 Collins, P. L., "Viral and host factors in human respiratory syncytial virus pathogenesis" J. Virol 82 : 2040 ~ 2055 -, 2008

2 Huang, S., "Upregulation of TLR7 and TLR3 gene expression in the lung of respiratory syncytial virus infected mice" Wei Sheng Wu Xue Bao 49 : 239 ~ 245 -, 2009

3 Vermeulen, L., "Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)" EMBO J 22 : 1313 ~ 1324 -, 2003

4 Conzelmann, K. K., "Transcriptional activation of alpha/ beta interferon genes: interference by nonsegmented negative-strand RNA viruses" J. Virol 79 : 5241 ~ 5248 -, 2005

5 Inoue, Y., "Toll-Like Receptor 2 as a Functional Receptor to Respiratory Syncytial Virus" J. Allergy Clin. Immunol 117 : S210 ~ -, 2006

6 Ehl, S., "The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus" Eur. J. Immunol 34 : 1146 ~ 1153 -, 2004

7 Dejardin, E., "The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways" Immunity 17 : 525 ~ 535 -, 2002

8 Segovia, J., "TLR2/MyD88/NF-kappaB pathway, reactive oxygen species, potassium efflux activates NLRP3/ ASC inflammasome during respiratory syncytial virus infection" PLoS One 7 : e29695 ~ -, 2012

9 Puthothu, B., "TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease" Dis. Markers 22 : 303 ~ 308 -, 2006

10 Wu, B., "Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5" Cell 152 : 276 ~ 289 -, 2013

11 Ramaswamy, M., "Specific inhibition of type I interferon signal transduction by respiratory syncytial virus" Am. J. Respir. Cell. Mol. Biol 30 : 893 ~ 900 -, 2004

12 Shingai, M., "Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction" Int. Immunol 20 : 1169 ~ 1180 -, 2008

13 Marr, N., "Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication" Innate. Immun 18 : 856 ~ 865 -, 2012

14 Ventre, K, "Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children" Cochrane Database Syst. Rev, 2007

15 Liu, P., "Retinoic Acid-Inducible Gene I Mediates Early Antiviral Response and Toll-Like Receptor 3 Expression in Respiratory Syncytial Virus-Infected Airway Epithelial Cells" J. Virol 81 : 1401 ~ 1411, 2007

16 Fulginiti, V. A., "Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine" Am. J. Epidemiol 89 : 435 ~ 448 -, 1969

17 Yoboua, F., "Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta" J. Virol 84 : 7267 ~ 7277 -, 2010

18 Crowe, J. E., Jr., "Respiratory syncytial virus vaccine development" Vaccine 20 (Suppl 1) : S32 ~ S37 -, 2001

19 Lo, M. S., "Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness" J. Virol 79 : 9315 ~ 9319 -, 2005

20 Takeuchi, R, "Respiratory syncytial virus infection of human alveolar epithelial cells enhances interferon regulatory factor 1 and interleukin-1beta-convertInnate immune recognition of respiratory syncytial virus infection Tae Hoon Kim and Heung Kyu Lee http://bmbreports.org BMB Reports 191 ing enzyme gene expression but does not cause apoptosis" J. Virol 72 : 4498 ~ 4502 -, 1998

21 Dou, Y., "Respiratory syncytial virus infection induces higher Toll-like receptor-3 expression and TNF-alpha production than human metapneumovirus infection" PLoS One 8 : e73488 ~ -, 2013

22 Jamaluddin, M., "Respiratory syncytial virus infection induces a reactive oxygen species-MSK1-phospho-Ser-276 RelA pathway required for cytokine expression" J. Virol 83 : 10605 ~ 10615 -, 2009

23 Vissers, M., "Respiratory syncytial virus infection augments NOD2 signaling in an IFN-beta-dependent manner in human primary cells" Eur. J. Immunol 42 : 2727 ~ 2735 -, 2012

24 Liu, P., "Respiratory syncytial virus induces RelA release from cytoplasmic 100-kDa NF-kappa B2 complexes via a novel retinoic acid-inducible gene-I{middle dot}NF- kappa B-inducing kinase signaling pathway" J. Biol. Chem 283 : 23169 ~ 23178 -, 2008

25 Murawski, M. R., "Respiratory syncytial virus activates innate immunity through Toll-like receptor 2" J. Virol 83 : 1492 ~ 1500 -, 2009

26 Connors, M., "Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived" J. Virol 65 : 1634 ~ 1637 -, 1991

27 Lukacs, N. W., "Respiratory Virus-Induced TLR7 Activation Controls IL-17-Associated Increased Mucus via IL-23 Regulation" J. Immunol 185 : 2231 ~ 2239 -, 2010

28 Haeberle, H. A., "Respiratory Syncytial Virus-Induced Activation of Nuclear Factor-κB in the Lung Involves Alveolar Macrophages and Toll-Like Receptor 4-Dependent Pathways" J. Infect. Dis 186 : 1199 ~ 1206 -, 2002

29 Monick, M. M., "Respiratory Syncytial Virus Up-regulates TLR4 and Sensitizes Airway Epithelial Cells to Endotoxin" J. Biol. Chem 278 : 53035 ~ 53044 -, 2003

30 Groskreutz, D. J., "Respiratory Syncytial Virus Induces TLR3 Protein and Protein Kinase R, Leading to Increased Double- Stranded RNA Responsiveness in Airway Epithelial Cells" J. Immunol 176 : 1733 ~ 1740 -, 2006

31 Blount, R. E., Jr, "Recovery of cytopathogenic agent from chimpanzees with coryza" Proc. Soc. Exp. Biol. Med 92 : 544 ~ 549 -, 1956

32 Chanock, R., "Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children" Am. J. Hyg 66 : 291 ~ 300 -, 1957

33 Chanock, R., "Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization" Am. J. Hyg 66 : 281 ~ 290 -, 1957

34 Pichlmair, A., "RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates" Science 314 : 997 ~ 1001 -, 2006

35 Rehwinkel, J., "RIG-I detects viral genomic RNA during negative-strand RNA virus infection" Cell 140 : 397 ~ 408 -, 2010

36 Haynes, L. M., "Progress and challenges in RSV prophylaxis and vaccine development" J. Infect. Dis 208 (Suppl 3) : S177 ~ S183 -, 2013

37 Davidson, S., "Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway" J. Immunol 186 : 5938 ~ 5948 -, 2011

38 Sasaki, C. Y., "Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway" J. Biol. Chem 280 : 34538 ~ 34547 -, 2005

39 Zhong, H., "Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300" Mol. Cell 1 : 661 ~ 671 -, 1998

40 Arnold, R., "Peroxisome proliferator- activated receptor-gamma agonists inhibit the replication of respiratory syncytial virus (RSV) in human lung epithelial cells" Virology 350 : 335 ~ 346 -, 2006

41 Kurt-Jones, E. A., "Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus" Nat. Immunol 1 : 398 ~ 401 -, 2000

42 Kumar, H., "Pathogen recognition by the innate immune system" Int. Rev. Immunol 30 : 16 ~ 34 -, 2011

43 Xiao, G., "NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100" Mol. Cell 7 : 401 ~ 409 -, 2001

44 Bhoj, V. G., "MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus" Proc. Natl. Acad. Sci. U. S. A 105 : 14046 ~ 14051 -, 2008

45 Haynes, L. M., "Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus" J. Virol 75 : 10730 ~ 10737 -, 2001

46 Schlender, J., "Inhibition of Toll-Like Receptor 7- and 9-Mediated Alpha/Beta Interferon Production in Human Plasmacytoid Dendritic Cells by Respiratory Syncytial Virus and Measles Virus" J. Virol 79 : 5507 ~ 5515 -, 2005

47 Pang, I. K., "Inflammasomes as mediators of immunity against influenza virus" Trends Immunol 32 : 34 ~ 41 -, 2011

48 Xiao, G., "Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation" J. Biol. Chem 279 : 30099 ~ 30105 -, 2004

49 Gagro, A., "Increased Toll-like receptor 4 expression in infants with respiratory syncytial virus bronchiolitis" Clin. Exp. Immunol 135 : 267 ~ 272 -, 2004

50 Walsh, E. E., "Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection" J. Infect. Dis 155 : 1198 ~ 1204 -, 1987

51 Demoor, T., "IPS-1 signaling has a nonredundant role in mediating antiviral responses and the clearance of respiratory syncytial virus" J. Immunol 189 : 5942 ~ 5953 -, 2012

52 Triantafilou, K., "Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation" Thorax 68 : 66 ~ 75 -, 2013

53 Inohara, N., "Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease" J. Biol. Chem 278 : 5509 ~ 5512 -, 2003

54 Scagnolari, C., "Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus- associated acute bronchiolitis" Clin. Vaccine Immunol 16 : 816 ~ 823 -, 2009

55 Chen, L. F., "F-kappaB RelA phosphorylation regulates RelA acetylation" Mol. Cell. Biol 25 : 7966 ~ 7975 -, 2005

56 Phipps, S., "Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus" Blood 110 : 1578 ~ 1586 -, 2007

57 Loo, Y. M., "Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity" J. Virol 82 : 335 ~ 345 -, 2008

58 Rudd, B. D., "Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression" J. Virol 79 : 3350 ~ 3357 -, 2005

59 Rudd, B. D., "Deletion of TLR3 Alters the Pulmonary Immune Environment and Mucus Production during Respiratory Syncytial Virus Infection" J. Immunol 176 : 1937 ~ 1942 -, 2006

60 장준, "Current progress on development of respiratory syncytial virus vaccine" BMB Reports 44 (4) : 232 ~ 237, 2011

61 Paulus, S. C., "Common human Toll-like receptor 4 polymorphisms-Role in susceptibility to respiratory syncytial virus infection and functional immunological relevance" Clin. Immunol 123 : 252 ~ 257 -, 2007

62 Zandi, E., "Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex" Mol. Cell Biol 19 : 4547 ~ 4551 -, 1999

63 Marr, N., "Attenuation of Respiratory Syncytial Virus-Induced and RIG-I-Dependent Type I IFN Responses in Human Neonates and Very Young Children" J. Immunol 192 : 948 ~ 957 -, 2014

64 Awomoyi, A. A., "Association of TLR4 polymorphisms with symptomatic respiratory syncytial virus infection in high-risk infants and young children" J. Immunol 179 : 3171 ~ 3177 -, 2007

65 Tal, G., "Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease" J. Infect. Dis 189 : 2057 ~ 2063 -, 2004

66 Sabbah, A., "Activation of innate immune antiviral responses by Nod2" Nat. Immunol 10 : 1073 ~ 1080 -, 2009

67 Hornung, V., "5'-Triphosphate RNA is the ligand for RIG-I" Science 314 : 994 ~ 997 -, 2006